All News

This time around, newfound joy and passion have added a different layer to Scanxiety.

From the first child born to a patient with cancer from an egg matured in a lab to women with breast cancer taking to the runway for New York Fashion Week, here’s what is making headlines in the cancer space this week.

The Clinical Treatment Act was created to expand clinical trial access to patients insured by Medicaid.

A cancer survivor discusses the ongoing emotional roller coaster ride of cancer survivorship.

Anyone who wants to enroll in a clinical trial should first weigh all the details. Patients should ask key questions like these before signing up.

A man with breast cancer looks at diet, data and breast density in relation to how he got his cancer.

It’s important to match therapies to goals and fitness when treating older patients diagnosed with cancer.

MK-6482 demonstrated an objective response rate of 24% among patients with advanced clear cell renal cell carcinoma, according to study findings presented at the 2020 Genitourinary Cancers Symposium.

The Food and Drug Administration granted a priority review to the new drug application for lurbinectedin to treat patients with small cell lung cancer.

On every cancer journey we need a strong support group to provide strength, acceptance and love — for one patient with cancer their spouse stepped into that role and beyond.

After five years of follow-up, treatment with Opdivo in those with previously treated advanced or metastatic renal cell carcinoma induced superior survival outcomes.

More than 50% of patients with previously untreated advanced or metastatic renal cell carcinoma were alive at 42 months after being treated with Opdivo plus Yervoy.

Hair loss, a common side effect of some chemo drugs, affects us all in different ways. Yet when hair grows back differently, it becomes a reminder of the changes that come with a diagnosis of cancer.

The Food and Drug Administration granted a final approval to pemfexy, a branded alternative chemotherapy injection for patients with advanced or metastatic nonsquamous non-small cell lung cancer, potentially offering them a cheaper treatment option in the future.

The Opioid epidemic is a concern for all of us but especially for those struggling with extreme cancer-related pain.

The combination of Padcev plus Keytruda induced a high rate of durable objective response rates in patients with locally advanced or metastatic urothelial cancer.

A cancer survivor often contemplates which is the lesser of two evils – cancer or treatment?

Words of courage from a friend who knows that "getting through" may not be the point.

From thousands of patients with breast cancer told to be re-checked after a surgeon performed botched surgeries to three young brothers receiving the same eye cancer diagnosis, here’s what is making headlines in the cancer space this week.

It’s no surprise that patients with cancer might become depressed, but now researchers say depression could precede a diagnosis. Here’s what you should know about the link between these two conditions.

Gratitude is my ultimate coping tool for managing my cancer survivorship.

Children with higher birth weight and body mass index, as well as taller height, are at a greater risk of developing renal cell carcinoma later in life, according to new study findings.

HPV and Anal cancer are associated with one another, here's what you need to know.

The LGBT community is faced with a disproportionate cancer burden that needs to be addressed.

Cancer treatment can take a toll on sexual health, but multiple therapies can help ease these undiscussed side effects. To get help, speak up.

Cancer, like many things in history, can be an unexpected landmark in our lives. With it can come crushing fear. If you feel that, even years after that moment in time, you are not alone.

Personal health information isn’t truly private: Medical practices share records and companies sell internet search details. Here’s what patients should know.

The effects of the cancer journey extend to every member of the family, and children will often handle it differently than adults.

The Food and Drug Administration granted a priority review to KTE-X19 for the treatment of adult patients with relapsed or refractory mantle cell lymphoma.

The story of a Bamba, a Granddaddy, a parachute man and the anticipation to get through another procedure.